07Nov

Cytox appoints new CCO

cytox-logo

Oxford and Manchester, UK – Cytox, a precision medicine company focused on developing solutions to identify individuals most at risk for developing Alzheimer's disease and dementia, today announced the appointment of Antony Hill as Chief Commercial Officer.

“We are pleased to welcome Tony Hill to the Cytox team,’ commented Cytox CEO, Dr Richard Pither, He joins us at a very exciting time for Cytox. This year we announced several important new collaborations and funding from Innovate UK and presented results on our recent advancements at all the major conferences, including how we identify Alzheimer’s disease risk in ApoE3 homozygote individuals, and also identify those individuals most likely to progress from mild cognitive impairment to Alzheimer’s.

“Tony has been involved in the diagnostics and molecular life sciences industry for 30 years, with senior roles in sales and marketing in international diagnostics and molecular life science companies including TwistDx Ltd (part of Abbott Diagnostics), Diasorin Molecular, Innogenetics and Sigma-Aldrich. He will greatly strengthen our management team and enable us to progress our partnerships and develop our clinical products.”

Related

New Partnership for Biological Sample Transport Solutions

Specialist Laboratory and Diagnostics supply company Alpha Laboratories Ltd. (Eastleigh, UK) is deli...

Read More >

SpeeDx receives FDA clearance for Mycoplasma genitalium product

SYDNEY, AUSTRALIA – (April 19, 2018). SpeeDx’s ResistancePlus® MG Positive Control kit has now bee...

Read More >

MBM and OCB launch ColoProg in China on March 7th 2018

Oxford developed prognostic assay for risk of post-surgical recurrence in Stage II colorectal cance...

Read More >

D-dimer point-of-care testing for DVT considered ‘game-changer’ in ambulatory care

Crawley, UK – 07 February 2019 – Radiometer Limited’s AQT90 FLEX analysers have been used in a su...

Read More >

Evaluation studies confirm improved oncology patient pathways through HORIBA Medical’s new POC haematology analyser

Yumizen H500 full blood count analyser demonstrates exceptional correlation with larger laboratory-b...

Read More >

OGT launches enhanced SureSeq™ Interpret NGS analysis software

Powerful, flexible and easy-to-use analysis solution gets the most out of NGS data

Read More >